에 대한 최신 뉴스 Meituan (OTC:MPNGY) 주식

Meituan is the largest food delivery platform in China, with a 60%-70% share of the market in 2024, according to Morningstar estimates. In the third quarter of 2024, the firm generated 74% of its revenue from the core local commerce segment, which includes on-demand food delivery and retail, in-store services (such as visiting beauty and entertainment stores after purchasing deals on Meituan), and hotel and travel booking. The remaining 26% of revenue came from the new initiatives segment, such as the community group purchase business Meituan Select and the overseas food delivery business.

Asia

Equities

News

Markets

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

BIDU

JDCMF

MPNGY

TCEHY

목요일(6일) 오전 홍콩 증시는 항셍지수가 2.5% 상승한 24,183.07포인트를 기록하며 2022년 1월 이후 최고치를 기록했다. 연간 상승률은 23.37%로 확대되었다.무슨 일 있었나: 홍콩증권거래소에서 중국 기술 대기업들이 랠리를 주도했다.

알리바바, 중국 정부의 AI 지원 약속에 주가 7% 상승...항셍지수 2년래 최고점

US CHINA Photo by Khanthachai C on Shutterstock

Tech

Media

MPNGF

NVDA

중국의 주요 기술 기업인 알리바바(NYSE:BABA), 바이트댄스, 메이투안(OTC:MPNGY)(OTC:MPNGF) 등이 실리콘밸리에서 인공지능(AI) 팀을 확장하고 있는 것으로 알려졌다.

알리바바, 바이트댄스, 메이투안 등 中 기술 대기업들, 실리콘밸리에서 AI 팀 확장 중인 이유는?

Meituan

Macro Economic Events

Macro Notification

Econ #s

Economics

General

S&P Global Manufacturing PMI For May 52.0 Vs 52.3 Est.; 50.2 Prior

Dark days lie ahead for U.S. consumers—that's the warning from billionaire investor <a href="https://www.benzinga.com/news/25/04/44630762/mark-cuban-says-black-women-entrepreneurs-should-stop-looking-for-funding-heres-the-surprising-reason-why">Mark Cuban</a>, who says American consumers are about to feel the real sting of the latest trade dispute.&nbsp;
In a sharply worded <a href="https://bsky.app/profile/mcuban.bsky.social/post/3lm5r643wvs2j">Bluesky post</a> on April 6, Cuban framed the escalating trade fight as a showdown between Elon Musk's free-trade ideals and President Donald Trump's full-tariff playbook. His take? Trump wins—and the U.S. economy loses.
"The stakes are enormous," Cuban warned, saying that Trump's aggressive tariff push may be a politically savvy move, but it's one that will drive up prices across the board. He warns the worst of the price hikes is still ahead.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
<h2 class="wp-block-heading">Tariffs Shelves And Sticker Shock</h2>
Cuban doubled down on that message in an April 9 <a href="https://bsky.app/profile/mcuban.bsky.social/post/3lmf7rp3ym22n">Bluesky thread</a>, saying many U.S. companies had rushed to stockpile goods in anticipation of Trump's tariffs—but those reserves are quickly drying up.&nbsp;
Once that cushion disappears, consumers will likely face a one-two punch of rising prices and job cuts as businesses scramble to cope with the new cost pressures.
Trump's tariff push started April 2 when the <a href="https://www.whitehouse.gov/presidential-actions/2025/04/regulating-imports-with-a-reciprocal-tariff-to-rectify-trade-practices-that-contribute-to-large-and-persistent-annual-united-states-goods-trade-deficits/">White House</a> rolled out a 10% &#8220;reciprocal&#8221; duty on imports from 185 countries. That quickly escalated: within a week, tariffs on Chinese goods jumped to 125%, making the total levy on imports from China 145%.
Beijing didn't waste time responding. Two days later, China <a href="http://us.china-embassy.gov.cn/eng/zmgx/zxxx/202504/t20250412_11593841.htm">raised its own duties</a> on U.S. imports by 125%.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
That trade barrage has since partially cooled. In <a href="https://www.reuters.com/world/china/us-china-reach-deal-slash-tariffs-officials-say-2025-05-12/">mid </a>May, the U.S. and China agreed to temporarily reduce tariffs for 90 days, dialing back U.S. import duties on Chinese goods from 145% to 30%, while China eased its tariffs to 10%, according to Reuters.
However, the agreement only covers a 90-day window, and businesses remain wary of what happens next. Retailers and importers say the limited relief <a href="https://www.axios.com/2025/05/21/tariffs-prices-kids-shoes">hasn't done enough </a>to reverse rising costs already baked into supply chains.
The tit-for-tat trade drama sent importers scrambling. By May, bookings for containers shipping from China to the U.S. jumped 277% as companies rushed to beat the clock before even more duties hit, according to <a href="https://www.reuters.com/business/autos-transportation/container-ship-owners-swamped-us-china-trade-detente-revives-demand-2025-05-16/">Reuters</a>.
Meanwhile, the cost to move goods surged. Spot freight rates from Shanghai to New York soared 19% to $4,350 per 40-foot container, while the Shanghai–Los Angeles route saw a 16% hike, shipping consultancy Drewry<a href="https://www.drewry.co.uk/supply-chain-advisors/supply-chain-expertise/world-container-index-assessed-by-drewry?utm_source=chatgpt.com"> reported</a>.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
That pressure is already hitting consumers. According to the <a href="https://www.bls.gov/news.release/cpi.nr0.htm">Bureau of Labor Statistics</a>, the consumer price index rose 0.2% in April and was 2.3% higher than a year earlier. Shelter and energy costs drove much of the increase, while food prices declined slightly.
Sensing what's ahead, Cuban urged Americans to take matters into their own hands—starting with their shopping carts. In an April 2 <a href="https://bsky.app/profile/mcuban.bsky.social/post/3llucjq4wkc2h">post on Bluesky</a>, Cuban advised his 1.4 million followers to stock up on essentials like toothpaste and soap before prices spike even further.&nbsp;
Cuban warned even goods made in&nbsp; the U.S. won't be immune from the inflationary wave as retailers pass on higher costs and blame<a href="https://www.benzinga.com/personal-finance/25/05/45409379/ben-shapiro-says-trumps-tariff-reversal-wasnt-4d-chess-it-was-just-people-getting-yippy-and-bond-markets-getting-queasy"> tariffs </a>for the surge. "Anything you can find storage space for," he wrote, should be bought now.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

Personal Finance

Dark Days Ahead For U.S. Consumers — Mark Cuban Says Trump Beat Musk In Tariff Fight, But Inflation Is Just Getting Started

B of A Securities analyst Ronald Epstein maintains Albany International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) with a Underperform and lowers the price target from $75 to $65.

Price Target

Analyst Ratings

B of A Securities Maintains Underperform on Albany International, Lowers Price Target to $65

Canaccord Genuity analyst Kingsley Crane maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy and raises the price target from $230 to $305.

Canaccord Genuity Maintains Buy on Zscaler, Raises Price Target to $305

Canaccord Genuity analyst Kingsley Crane maintains PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) with a Buy and lowers the price target from $23 to $21.

Canaccord Genuity Maintains Buy on PagerDuty, Lowers Price Target to $21

In the study in China, GFH375 demonstrated an ORR of 52% in patients with pancreatic ductal adenocarcinoma and an ORR of 42% with non-small cell lung cancer
Company activating sites in the U.S. for VS-7375 to begin enrollment in the Phase 1/2a trial
Company will host an R&amp;D investor webcast on Monday, June 2, at 11:00 am CDT to review updated RAMP 205 data as well as updated data on GFH375 presented at the ASCO 2025 Annual Meeting
Verastem Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced positive updated data from the dose escalation phase of the Phase 1/2 trial of GFH375 (known as VS-7375 in the U.S.). As of May 16, 2025, 23 efficacy-evaluable patients with pancreatic ductal adenocarcinoma (PDAC) and 12 efficacy-evaluable patients with non-small cell lung cancer (NSCLC) achieved an overall response rate (ORR) of 52% and 42%, respectively. The updated data were presented by Verastem's partner, GenFleet Therapeutics, in a rapid oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2025, in Chicago, IL.

VSTM

Verastem Oncology Announces Updated Data From Dose Escalation Phase Of The Phase 1/2 Trial Of GFH375; Study Shows ORR Of 52% In Patients With Pancreatic Ductal Adenocarcinoma And ORR Of 42% With Non-Small Cell Lung Cancer

Canaccord Genuity analyst Kingsley Crane maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Buy and raises the price target from $14 to $16.

PATH

Canaccord Genuity Maintains Buy on UiPath, Raises Price Target to $16

Investor presentations have traditionally served as a cornerstone of corporate strategy—an essential means for companies to communicate vision, performance, and growth potential to current and potential stakeholders. Today, with artificial intelligence (AI) becoming a transformative force across industries, the investor presentation process is undergoing a significant evolution. AI-powered tools are not only streamlining the creation of these decks but also enriching them with personalized insights, real-time data, and dynamic visualizations, meeting the escalating expectations of modern investors.
<h2 class="wp-block-heading">The Accelerated Growth of AI Presentation Software</h2>
The AI presentation software market is growing at a breakneck pace. <a href="https://www.verifiedmarketreports.com/product/ai-ppt-generation-software-market/">Verified Market Reports </a>recently valued the global AI PPT Generation Software Market at $1.25 billion in 2024. That figure is projected to skyrocket to $5.6 billion by 2033, reflecting an impressive compound annual growth rate (CAGR) of 18.5% between 2026 and 2033.
A clear shift in demand drives this surge: companies now require more efficient, high-quality, and data-driven presentation tools to keep up with the speed and complexity of financial communications.
<h3 class="wp-block-heading">3 Key Takeaways</h3>
<ul class="wp-block-list">
<li>The AI presentation software market is expected to grow more than fourfold by 2033. </li>
<li>Efficiency and accuracy are the primary drivers of adoption. </li>
<li>Investor expectations are trending toward data-rich, visually compelling communications. </li>
</ul>
<h2 class="wp-block-heading">AI-Driven Efficiency: A Game-Changer for Teams</h2>
Investor relations teams often spend a significant amount of time building and refining presentation decks. According to<a href="https://www.coveo.com/en/resources/reports/relevance-report-workplace?&amp;utm_source=press-release&amp;utm_medium=organic&amp;utm_campaign=relevance-report-2022-workplace"> research by Coveo</a>, employees spend an average of 3.6 hours per week preparing presentations, time that could otherwise be used for analysis or strategy.
AI-powered tools address this inefficiency by automating repetitive tasks such as content generation, data visualization, and layout design. This not only shortens turnaround times but also allows teams to focus on storytelling and refining their investment thesis.
<h2 class="wp-block-heading">From Static Decks to Dynamic Narratives</h2>
Historically, investor presentations have been static—built manually using generic templates and static data sets. But AI tools are rapidly changing that norm, enabling a move toward dynamic, adaptive presentations with intelligent content generation.
"The future of investor communications lies in smart automation," says Anand RK, founder of SlideBazaar AI. "With AI handling the heavy lifting of design and data formatting, companies can focus more on strategic messaging and less on the mechanics of slide creation."
These tools use natural language processing (NLP) and machine learning to generate content, optimize layouts, and visualize complex financial data, making professional-grade presentations accessible even to teams without design expertise.
<h2 class="wp-block-heading">Adoption Among Market Leaders: A Tale of Two Approaches</h2>
Forward-thinking companies are integrating AI into their investor communications. For example, expert.ai has pivoted its investor days to highlight its AI technology more effectively—a strategic shift mirrored by several peers.
Yet, some high-profile AI firms have been slower to adapt. When<a href="https://x.ai/"> Elon Musk's xAI</a> pitched investors, it did so using a traditional, static slide deck, highlighting a surprising lag between AI innovation and its application in investor communications.
This disconnect reveals a significant market opportunity. As investor expectations grow for transparency, clarity, and customization, AI-native companies will have a distinct advantage.
"AI can significantly enhance the creative process by enabling rapid experimentation and iteration, allowing for more innovative and unexpected outcomes," says PJ Pereira, Co-founder of Pereira &amp; O&#8217;Dell.
Related: <a href="https://www.benzinga.com/money/how-to-invest-in-ai-startups">How To Invest in AI Startups</a>
<h2 class="wp-block-heading">The New Standard: Features Defining Modern AI Tools</h2>
Today's AI presentation platforms go well beyond automation. They include robust features that align with corporate branding, facilitate collaboration, and provide actionable analytics.
<h3 class="wp-block-heading">3 Key Takeaways</h3>
<ul class="wp-block-list">
<li>Automated brand consistency ensures a professional, polished look. </li>
<li>Real-time analytics offer deep insights into investor engagement. </li>
<li>Seamless integration with platforms like Microsoft PowerPoint eases enterprise adoption. </li>
</ul>
These analytics tools allow companies to track how investors engage with their deck&#8217;s data, which can inform future communications and optimize for impact.
<h2 class="wp-block-heading">Personalization Through Real-Time Data</h2>
Perhaps the most compelling advancement in AI-powered presentation software is the ability to personalize content in real-time. By analyzing investor behavior, interests, and market dynamics, AI can tailor presentations to address specific segments.
Real-time data integration allows automatic updates to charts, KPIs, or market news, ensuring that presentations are always accurate and relevant. This builds credibility and demonstrates a commitment to transparency.
AI-powered templates are also customizable at scale, enabling companies to quickly tailor content for different audiences without starting from scratch.
<h2 class="wp-block-heading">The Broader Impact on Investor Relations Strategy</h2>
The integration of AI into presentation workflows is catalyzing a broader shift in investor relations strategies. Companies are moving away from generic, one-size-fits-all communications in favor of targeted, personalized storytelling supported by data.
Enterprise demand is rising for platforms that are secure, collaborative, and analytics-rich. These tools are increasingly seen as critical to both investor engagement and internal efficiency.
<h3 class="wp-block-heading">3 Key Takeaways</h3>
<ul class="wp-block-list">
<li>Personalized content fosters deeper investor trust. </li>
<li>Data-driven presentations lead to smarter investor decisions. </li>
<li>Secure, enterprise-grade platforms are driving adoption at scale. </li>
</ul>
<h2 class="wp-block-heading">A Shift in the Business Model</h2>
The business model for presentation tools is also evolving. Vendors are transitioning from low-cost, template-driven platforms to premium, enterprise-focused solutions with features like predictive analytics and cross-platform integrations.
For companies, this means more strategic investor engagement. For investors, it results in clearer, more actionable insights.
<h2 class="wp-block-heading">The Future: Smarter, More Immersive Investor Decks</h2>
Looking forward, AI&#8217;s role in investor presentations is poised to expand further with several game-changing trends:
<ul class="wp-block-list">
<li>Advanced reasoning will allow AI to craft more insightful narratives. </li>
<li>Multimodal content integration will bring together visuals, video, and interactive elements. </li>
<li>Real-time interactivity will enable decks that adapt to live investor feedback. </li>
</ul>
These advancements are set to redefine the investor experience, making presentations more intuitive, relevant, and compelling than ever before.
<h2 class="wp-block-heading">What This Means for Investors</h2>
For investors, <a href="https://www.benzinga.com/24/05/38615997/how-automation-tools-are-revolutionizing-the-investment-landscape-in-2024">the rise of AI in corporate communications</a> is a welcome development. Enhanced personalization, data transparency, and engagement make it easier to assess company performance and strategic potential.
These tools level the playing field, enabling both emerging startups and Fortune 500 companies to articulate their value proposition with clarity and impact.
<h2 class="wp-block-heading">Conclusion: A New Era for Investor Engagement</h2>
As investor expectations evolve in a data-driven, fast-paced world, so too must the tools companies use to communicate. AI-powered presentation platforms are revolutionizing the way companies tell their story, enhancing efficiency, clarity, and engagement.
Organizations seeking to lead in investor relations should explore integrating AI presentation tools into their workflow to help companies meet the demands of today's investment landscape- one that values not just numbers, but narrative, personalization, and precision.

Opinion

How Investor Presentations Are Evolving In The AI Era

Nordic American Tankers' Founder, Chairman & CEO, Herbjorn Hansson Buys 100.000 Shares In NAT At $2.70/Shr

&nbsp;FT Global Capital, Inc. ("FT Global"), a Miami Beach-based registered broker-dealer and investment banking firm, announced today the most recent development in its effort to enforce its judgment against Future FinTech Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) ("Future FinTech"). Following the U.S. District Court's Order granting FT Global's Motions for Turnover of Unissued Stock and Bank Funds (the "Court Order"), the U.S. Marshal or its representatives will hold a public auction in front of Room&nbsp;850 of the Courthouse for the United States District Court for the Southern District of New York, 500 Pearl Street, New York, New York 10007 on June&nbsp;12, 2025, at 12:00&nbsp;noon, of 1,951,443 shares of FTFT common stock (the "Securities").
At this auction, the Securities will be sold "as is," without any warranty, and subject to any and all encumbrances, if any. The Securities have not been registered under the U.S. Securities Act of 1933, as amended, and will be issued with customary restrictive legends. The Securities will be offered solely to "accredited investors," as that term is defined in the federal securities regulations. Any purchaser of the Securities must be prepared to comply with all reporting obligations under the federal securities law. Information about FTFT is available on the Securities and Exchange Commission EDGAR website. The auction of the Securities is not a public offering.
On April&nbsp;16, 2024, the U.S. District Court for the Northern District of Georgia entered an Amended Judgment in favor of FT Global against Future FinTech in the approximate amount of $10.8&nbsp;million. FT Global has entered the Amended Judgment in the Southern District of New York, among other courts. To date, a significant portion of the Amended Judgment remains unpaid. FT Global intends to work with the U.S. Marshal in connection with the Court Order to pay down the Amended Judgment.
FT Global will continue with its enforcement effort domestically and in foreign jurisdictions, as may be appropriate, against Future FinTech and its officers and directors.

Legal

FTFT

FT Global Capital To Auction Nearly 2M Shares Of Future FinTech Common Stock In U.S. District Court Following Court Order, Seeking To Enforce $10.8M Judgment Amid Ongoing Domestic And International Legal Actions Against Future FinTech

BMO Capital analyst Evan David Seigerman maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Outperform and lowers the price target from $800 to $600.

REGN

BMO Capital Maintains Outperform on Regeneron Pharmaceuticals, Lowers Price Target to $600

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Truist Securities raised Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) price target from $89 to $100. Truist Securities analyst Scot Ciccarelli maintained a Buy rating. Dollar Tree shares closed at $90.26 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">view this stock</a>.</li>
<li>Keybanc slashed the price target for UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) from $450 to $400. Keybanc analyst Matthew Gillmor maintained an Overweight rating. UnitedHealth shares closed at $301.91 on Friday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James raised Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) price target from $74 to $79. Raymond James analyst John Davis maintained an Outperform rating. Block shares closed at $61.75 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/xyz/analyst-ratings">view this stock</a>.</li>
<li>Wedbush increased the price target for Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) from $128 to $129. Wedbush analyst David Nierengarten downgraded the stock from Outperform to Neutral. Blueprint Medicines shares closed at $101.35 on Friday. <a href="https://www.benzinga.com/quote/bpmc/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho increased the price target for SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from $15 to $18. Mizuho analyst Maheep Mandloi maintained a Neutral rating. SolarEdge Technologies shares closed at $17.86 on Friday. <a href="https://www.benzinga.com/quote/sedg/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS raised SPX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPXC#NYSE">SPXC</a>) price target from $160 to $182. UBS analyst Damian Karas upgraded the stock from Neutral to Buy. SPX Technologies shares settled at $152.09 on Friday. <a href="https://www.benzinga.com/quote/spxc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley increased EOG Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) price target from $132 to $135. Morgan Stanley analyst Devin McDermott maintained an Equal-Weight rating. EOG Resources shares closed at $108.57 on Friday. <a href="https://www.benzinga.com/quote/eog/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies raised Rollins, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) price target from $55 to $65. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. Rollins shares closed at $57.24 on Friday.  <a href="https://www.benzinga.com/quote/rol/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities increased the price target for The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) from $185 to $260. B of A Securities analyst Ronald Epstein upgraded the stock from Neutral to Buy. Boeing shares settled at $207.29 on Friday. <a href="https://www.benzinga.com/quote/ba/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs raised Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) price target from $45 to $65. Goldman Sachs analyst Jordan Alliger upgraded the stock from Neutral to Buy. Knight-Swift Transportation shares closed at $44.32 on Friday. <a href="https://www.benzinga.com/quote/knx/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying BA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02093559/image-11-1024x579.png" alt="" class="wp-image-935238" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02093559/image-11-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02093559/image-11-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02093559/image-11-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02093559/image-11.png 1167w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/06/45719208/cramer-shouldve-told-investors-to-pull-the-trigger-on-trade-desk-cant-believe-how-low-gentex-has-fallen">Cramer: Should&#8217;ve Told Investors To &#8216;Pull The Trigger&#8217; On Trade Desk, Can&#8217;t Believe &#8216;How Low&#8217; Gentex Has Fallen</a> </li>
</ul>
Photo via Shutterstock

Trading Ideas

BPMC

DLTR

SEDG

SPXC

Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday

Management

FIBK

First Interstate BancSystem Appoints David Della Camera As EVP And CFO, Succeeding Marcy Mutch, Effective June 1, 2025

Guggenheim analyst Curry Baker maintains New York Times (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYT#NYSE">NYT</a>) with a Neutral and raises the price target from $53 to $55.

Guggenheim Maintains Neutral on New York Times, Raises Price Target to $55

BMO Capital analyst Daniel Jester maintains Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) with a Outperform and raises the price target from $48 to $54.

BMO Capital Maintains Outperform on Samsara, Raises Price Target to $54

OceanPal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) (the "Company"), a global shipping company specializing in the ownership of vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell the 2004-built dry bulk vessel "Protefs" to a third party, for a sale price of US$7 million before commissions with delivery to the buyer no later than June 17, 2025.
Upon completion of the aforementioned sale,&nbsp;OceanPal Inc.'s fleet will consist of 2 Panamax dry bulk vessels and an MR2 tanker vessel.

OceanPal Signs MOA To Sell 2004-Built Dry Bulk Vessel "Protefs" To Third Party For $7M Before Commissions With Delivery To Buyer No Later Than June 17, 2025

Innovex International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NYSE">INVX</a>) (the "Company" or "Innovex") is pleased to announce that it has completed the acquisition of Citadel Casing Solutions, LLC ("Citadel"), leveraging its unique, energy industrial platform. This investment meets all the criteria of the Company's disciplined M&amp;A framework, including a focus on single-use, highly engineered products that share the Company's "Big Impact, Small Ticket" value proposition.
Founded in 2016 by a team of industry experts, Citadel is a leading provider of differentiated downhole technologies which are designed to improve its customers' economics by driving reduced cycle times through improved operational efficiencies.
The acquisition is financially attractive even prior to expected synergies. The transaction values Citadel at approximately 3.8x LTM Adjusted EBITDA1 and is 8% accretive to Innovex's EPS2. Innovex anticipates realizing approximately $2 million of cost synergies within 3 months and anticipates further synergies longer term as the business is fully integrated.

INVX

Innovex International Completes Acquisition Of Citadel Casing Solutions; Transaction Valued At 3.8x LTM Adjusted EBITDA And Projected To Be 8% Accretive To EPS, With $2M In Cost Synergies Expected Within 3-Months

HC Wainwright &amp; Co. analyst Matthew Kelsey assumes Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) with a Buy rating and announces Price Target of $5.

Initiation

SNSE

HC Wainwright & Co. Assumes Sensei Biotherapeutics at Buy, Announces Price Target of $5

MiNK Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced it has been awarded a grant from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH). The grant will support development of MiNK's allo-iNKT cell therapy platform for the prevention and treatment of graft-versus-host disease (GvHD) following hematopoietic stem cell transplantation (HSCT), in collaboration with the University of Wisconsin.

INKT

MiNK Therapeutics Awarded Grant From NIAID To Support Development Of MiNK's Allo- iNKT Cell Therapy Platform For Prevention And Treatment Of GvHD

One-time Amtagvi Treatment Continues to Show&nbsp; Deep, Durable Responses and Meaningful Survival
One Third of Responses Remain Ongoing without Subsequent Treatment after Five Years
Simultaneous Presentation at ASCO 2025

Biotech

IOVA

Iovance Biotherapeutics Publishes Final Analysis Of Phase 2 C-144-01 Clinical Trial Evaluating Individualized T Cell Therapy Amtagvi In Patients With Advanced Melanoma In Journal of Clinical Oncology.

목요일(6일) 오전 홍콩 증시는 항셍지수가 2.5% 상승한 24,183.07포인트를 기록하며 2022년 1월 이후 최고치를 기록했다. 연간 상승률은 23.37%로 확대되었다.
무슨 일 있었나: 홍콩증권거래소에서 중국 기술 대기업들이 랠리를 주도했다. 알리바바 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)(OTC:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#OTC">BABAF</a>) 주가가 7.24% 상승한 139.30 HKD($17.93), 텐센트(OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>) 주가가 5.84% 상승한 534.00 HKD($68.72)에 거래되었다.
다른 주요 기술 기업들도 상당한 상승세를 보였는데 바이두(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)는 3.83% 상승하여 90.80 HKD($11.68), JD닷컴(OTC:<a class="ticker" href="https://www.benzinga.com/stock/JDCMF#OTC">JDCMF</a>)은 4.06% 상승하여 171.20 HKD($22.03), 메이투안(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPNGY#OTC">MPNGY</a>)은 4.08% 상승하여 179.50 HKD($23.10)에 거래되었다.
로이터 통신은 수요일 중국 전국인민대표대회에서 리창 총리가 재정 부양책을 확대하겠다고 발표한 이후 시장 랠리가 이어졌다고 보도했다. 리 총리는 부진한 소비를 "적극적으로 부양"하고 미국 무역 긴장 고조로 인한 충격을 완화하는 동시에 2025년 중국의 5% 성장 목표를 유지하겠다고 약속했다.
리 총리는 "점점 더 복잡하고 어려워지는 외부 환경이 무역, 과학, 기술 등의 분야에서 중국에 더 큰 영향을 미칠 수 있다"고 경고하며 "한 세기 동안 보지 못한 변화"를 언급했다.
왜 중요한가: 중국은 올해 1.3조 위안(1,790 억 달러)의 초장기 특별 국채를 발행할 계획이며 2024년 1조 위안보다 증가한 수치다. 또한 지방 정부가 4.4조 위안의 특별 부채를 발행할 수 있도록 허용할 것이며, 예산 적자는 GDP의 약 4%까지 확대될 것으로 예상된다.
투자자들은 특히 리 총리가 전기차, 스마트폰, 로봇 전반에 걸쳐 인공지능(AI) 애플리케이션을 육성하겠다고 약속하면서 중국의 AI 야망에 열광하고 있는 것으로 보인다. 최근 AI 플랫폼 딥시크의 등장으로 시장 분위기는 더욱 고조되었으며, 알리바바도 오늘 새로운 QwQ-32B 추론 모델을 발표했다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Today, we release QwQ-32B, our new reasoning model with only 32 billion parameters that rivals cutting-edge reasoning model, e.g., DeepSeek-R1.
Blog: <a href="https://t.co/zCgACNdodj">https://t.co/zCgACNdodj</a> HF: <a href="https://t.co/pfjZygOiyQ">https://t.co/pfjZygOiyQ</a> ModelScope: <a href="https://t.co/hcfOD8wSLa">https://t.co/hcfOD8wSLa</a> Demo: <a href="https://t.co/DxWPzAg6g8">https://t.co/DxWPzAg6g8</a> Qwen Chat:… <a href="https://t.co/kfvbNgNucW">pic.twitter.com/kfvbNgNucW</a>
&mdash; Qwen (@Alibaba_Qwen) <a href="https://twitter.com/Alibaba_Qwen/status/1897361654763151544?ref_src=twsrc%5Etfw">March 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
이미지 출처: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

중국의 주요 기술 기업인 알리바바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), 바이트댄스, 메이투안(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPNGY#OTC">MPNGY</a>)(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MPNGF#OTC">MPNGF</a>) 등이 실리콘밸리에서 인공지능(AI) 팀을 확장하고 있는 것으로 알려졌다.
무슨 일 일어났나: <a href="https://www.ft.com/content/da8c29b0-0a90-4d2a-8535-c8459ccc7bb4">파이낸셜타임스 보도에 따르면</a> 중국 기술 대기업들은 최근 수익성 높은 AI 부문에서 우위를 점할 수 있도록 미국 최고의 인재를 유치하기 위해 캘리포니아에 기반을 둔 사무소를 확장하고 있다.
알리바바는 국제 상거래에 대한 광범위한 추진의 일환으로 검색엔진 AI인 아씨오(Accio)를 위한 엔지니어, 제품 관리자 및 AI 연구원을 채용하고 있다. 메이퇀은 AI 기반 메뉴 번역과 같은 기능에 중점을 둔 팀을 구성하고 있으며, 바이트댄스는 두바오(Doubao) 언어 모델을 지속적으로 개발하고 AI를 틱톡에 통합하고 있다.
이러한 확장은 미국이 AI 모델 개발에 필수적인 엔비디아의 하이엔드 AI 칩을 중국 기업에 <a href="https://www.benzinga.com/news/24/10/41323155/nvidia-amd-face-chip-export-curbs-as-biden-administration-considers-restrictions-on-middle-east-coun">수출하는 것을 금지한 상황</a>에서도 이루어졌다. 중국 기술 기업과 관련이 있거나 소유한 미국 기반 법인이 미국 데이터 센터를 통해 하이엔드 AI 칩에 액세스하는 데는 제한이 없다.
그러나 해당 보도는 미국 상무부가 지난 1월 클라우드 제공업체가 AI 모델을 훈련하는 사용자의 신원을 확인하고 활동을 보고하도록 요구하는 규칙을 제안했다고도 지적했다.
<a href="https://bztechtrends.beehiiv.com/subscribe">벤징가 테크 트렌드 뉴스레터</a>를 구독하고 최신 기술 개발 소식을 받아보세요.
왜 중요한가: 실리콘밸리에서 이러한 중국 거대 기술 기업의 확장은 미중 긴장이 고조되는 가운데 이루어지고 있다. 도널드 트럼프의 재선 성공 이후 양국 간의 <a href=""https://www.benzinga.com/government/24/11/41773691/us-listed-chinese-stocks-like-alibaba-jd-nio-fall-after-trumps-win-whats-going-on"">포괄적인 무역 갈등</a>이 발생할 수 있다는 우려가 있었다.
트럼프가 제안한 중국산 제품에 대한 60% 관세는 <a href="https://www.benzinga.com/markets/24/11/42028954/peter-thiel-says-trumps-60-china-tariff-would-be-very-very-bad-for-beijing-heres-whats-at-stake">중국 기업에 큰 영향을 미칠 것</a>으로 예상된다. 이에 트럼프의 승리 이후 알리바바, 징동닷컴, 니오 등 미국에 상장된 중국 주식은 하락세를 보였다.
그러나 시진핑 중국 국가주석은 집권하는 행정부와 상관없이 미국 정부와 <a href="https://www.benzinga.com/24/11/42025284/xi-jinping-tells-joe-biden-china-is-ready-to-work-with-trump-as-tariff-threat-looms">협력하겠다는 의지를 표명</a>했다.
그는 리마에서 열린 아시아태평양 경제협력체 포럼에서 조 바이든 미국 대통령에게 "중국은 양국 국민의 이익을 위해 대화를 유지하고, 협력을 확대하고, 입장 차이를 관리하기 위해 미국 정부와 협력할 준비가 되어 있다&#8221;고 말했다.
이미지 제공: 위키미디어 커먼즈 
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Meituan

뉴스

에 대한 최신 뉴스 Meituan (OTC:MPNGY) 주식

목요일, 3월 06, 2025

화요일, 11월 19, 2024

뉴스

파트너 / 기고자

벤징가 글로벌